These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Peripheral vasodilators in the treatment of heart failure]. Serbin VI; Gasanova AS Pediatriia; 1982 Jan; (1):67-70. PubMed ID: 7038611 [No Abstract] [Full Text] [Related]
47. [Use of vasodilator agents in circulatory insufficienty]. Halawa B Wiad Lek; 1979 Nov; 32(22):1617-20. PubMed ID: 120075 [No Abstract] [Full Text] [Related]
48. Use of vasodilator drugs in congestive heart failure. Med Lett Drugs Ther; 1978 Oct; 20(20):89-91. PubMed ID: 703684 [No Abstract] [Full Text] [Related]
49. Vasodilator and inotropic therapy of heart failure [panel discussion]. Am J Med; 1978 Jul; 65(1):208-16. PubMed ID: 685996 [No Abstract] [Full Text] [Related]
50. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)]. Solignac A Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422 [TBL] [Abstract][Full Text] [Related]
51. Current indications for vasodilator therapy for left ventricular failure. Franciosa JA Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926 [No Abstract] [Full Text] [Related]
52. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031 [TBL] [Abstract][Full Text] [Related]
53. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure]. Kersting F; Samosny G; Kasper W; Schuster HP Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383 [No Abstract] [Full Text] [Related]
55. Is there a drug of choice for vasodilator therapy in patients with refractory heart failure? Packer M Chest; 1980 Jan; 77(1):7-9. PubMed ID: 7351152 [No Abstract] [Full Text] [Related]
56. Vasodilators for chronic congestive heart failure. Med Lett Drugs Ther; 1984 Dec; 26(677):115-6. PubMed ID: 6390110 [No Abstract] [Full Text] [Related]
57. Electrophysiologic properties of hydralazine in man. Gould L; Reddy CV; Zen B; Singh BK; Becker WH Pacing Clin Electrophysiol; 1980 Sep; 3(5):548-54. PubMed ID: 6160553 [TBL] [Abstract][Full Text] [Related]
58. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine. Schofield PM; Brooks NH; Lawrence GP; Testa HJ; Ward C Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167 [TBL] [Abstract][Full Text] [Related]